A two-pronged anti-leukemic agent based on a hyaluronic acid-green tea catechin conjugate for inducing targeted cell death and terminal differentiation. [electronic resource]
Producer: 20200414Description: 497-505 p. digitalISSN:- 2047-4849
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Catechin -- administration & dosage
- Cell Death -- drug effects
- Cell Differentiation -- drug effects
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- HEK293 Cells
- HL-60 Cells
- Human Umbilical Vein Endothelial Cells
- Humans
- Hyaluronic Acid -- administration & dosage
- Leukemia, Myeloid, Acute -- drug therapy
- Male
- Mice
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.